# Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

> **NCT00019188** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Epidemic Kaposi's Sarcoma
- Recurrent Kaposi's Sarcoma

## Interventions

- **DRUG:** interleukin-12

## Key facts

- **NCT ID:** NCT00019188
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019188, "Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00019188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*